| 000 | 01416 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517145745.0 | ||
| 264 | 0 | _c20191021 | |
| 008 | 201910s 0 0 ger d | ||
| 022 | _a1439-3999 | ||
| 024 | 7 |
_a10.1055/s-0043-103002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDithmer, M | |
| 245 | 0 | 0 |
_a[Uveal Melanoma Cell Under Oxidative Stress - Influence of VEGF and VEGF-Inhibitors]. _h[electronic resource] |
| 260 |
_bKlinische Monatsblatter fur Augenheilkunde _cMar 2019 |
||
| 300 |
_a295-307 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAngiogenesis Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aUveal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aUveal Melanoma |
| 700 | 1 | _aKirsch, A M | |
| 700 | 1 | _aGräfenstein, L | |
| 700 | 1 | _aWang, F | |
| 700 | 1 | _aSchmidt, H | |
| 700 | 1 | _aCoupland, S E | |
| 700 | 1 | _aFuchs, S | |
| 700 | 1 | _aRoider, J | |
| 700 | 1 | _aKlettner, A K | |
| 773 | 0 |
_tKlinische Monatsblatter fur Augenheilkunde _gvol. 236 _gno. 3 _gp. 295-307 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0043-103002 _zAvailable from publisher's website |
| 999 |
_c27048838 _d27048838 |
||